Skip to search formSkip to main contentSkip to account menu

Palladone

Hydromorphone hydrochloride extended release.
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

HydromorphoneHydromorphone Hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Comparative In Vitro Dissolution Testing of Hydrophilic Controlled-Release Venlafaxine Matrix Tablets and Effexor XR Using QbD
A hydrophilic matrix-based, controlled-release formulation for venlafaxine HCl (Ven HCl) was developed using a combination of… 
2007
2007
Dose dumping and the dumping of doses.
This past summer, a neighbor recommended a novel by the Swedish mystery writer, Henning Mankell. An enjoyable and well-crafted… 
2005
2005
Palladone for chronic pain.
Palladone is a new long-acting formulation of the opioid agonist hydromorphone that is taken once daily for treatment of chronic… 
2005
2005
FDA asks Purdue Pharma to withdraw Palladone.
2005
2005
Palladone (hydromorphone extended-release capsules)
2005
2005
With Palladone Pulled, FDA Eyes Other Opioids
2005
2005
Palladone Pulled; FDA Examines Related Opioids
2005
2005
With Palladone Pulled, FDA Looks at Other Opioids
2005
2005
Alcohol-associated rapid release of a long-acting opioid
Reason for posting: Palladone XL (hydromorphone hydrochloride) is a long-acting opioid for chronic pain relief in patients with… 
2005
2005
Caution when Seeking Information about Palladone; Patients Need Education about Proper Use of Inhalers; Shaken, Not Stirred; Pharmacy Intervention Trigger; Hot Flashes from Hot Patches
These medication errors have occurred in health care facilities at least once. They will happen again—perhaps where you work… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)